• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

协同细胞焦亡与细胞凋亡增强具有优异光稳定性的线粒体靶向菁染料的光疗作用。

Synergetic Pyroptosis with Apoptosis Improving Phototherapy of Mitochondria-Targeted Cyanines with Superior Photostability.

机构信息

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China.

State Key Laboratory of Southern Medicine Utilization, College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China.

出版信息

ACS Appl Mater Interfaces. 2024 Mar 13;16(10):12310-12320. doi: 10.1021/acsami.3c19205. Epub 2024 Feb 27.

DOI:10.1021/acsami.3c19205
PMID:38412031
Abstract

Pyroptosis has been reported to improve the antitumor effect by evoking a more intense immune response and a therapeutic effect. For phototherapy, several photosensitizers have been found to initiate pyroptosis. However, the effect of pyroptosis associated with apoptosis in enhancing the antitumor therapy needs sufficient characterization, especially under long-term treatment. As a NIR photosensitizer, heptamethine cyanines have been discovered for anticancer phototherapy for deep tissue penetration and inherent tumor-targeted capability. However, they are not quite stable for long-term performance. To investigate the effect of pyroptosis along with apoptosis on the anticancer immune responses and phototherapy, here, we chemically modulate the cyanine IR780 to regulate hydrophobicity, stability, and intracellular targeting. Two photosensitizers, T780T-TPP and T780T-TPP-C, were finally optimized and showed excellent photostability with high photothermal conversion efficiency. Although the cellular uptake of the two molecules was both mediated by OATP transporters, T780T-TPP induced tumor cell death via pyroptosis and apoptosis and accumulated in tumor accumulation, while T780T-TPP-C was prone to accumulate in the liver. Ultimately, via one injection-multiple irradiation treatment protocol, T780T-TPP displayed a significant antitumor effect, even against the growth of large tumors (200 mm).

摘要

细胞焦亡已被报道可通过引发更强烈的免疫反应和治疗效果来提高抗肿瘤作用。对于光疗,已经发现几种光敏剂可以引发细胞焦亡。然而,细胞焦亡与细胞凋亡协同增强抗肿瘤治疗的效果需要充分的特征描述,特别是在长期治疗下。作为一种近红外光敏剂,七甲川花菁已被发现用于癌症光疗,具有深层组织穿透和固有肿瘤靶向能力。然而,它们的长期性能并不稳定。为了研究细胞焦亡与细胞凋亡对癌症免疫反应和光疗的影响,我们对花菁 IR780 进行了化学修饰,以调节疏水性、稳定性和细胞内靶向性。最终优化了两种光敏剂 T780T-TPP 和 T780T-TPP-C,它们表现出优异的光稳定性和高光热转换效率。尽管这两种分子的细胞摄取都是通过 OATP 转运蛋白介导的,但 T780T-TPP 通过细胞焦亡和细胞凋亡诱导肿瘤细胞死亡,并在肿瘤部位积累,而 T780T-TPP-C 则容易在肝脏积累。最终,通过一次注射多次照射治疗方案,T780T-TPP 显示出显著的抗肿瘤效果,甚至可以抑制 200mm 大肿瘤的生长。

相似文献

1
Synergetic Pyroptosis with Apoptosis Improving Phototherapy of Mitochondria-Targeted Cyanines with Superior Photostability.协同细胞焦亡与细胞凋亡增强具有优异光稳定性的线粒体靶向菁染料的光疗作用。
ACS Appl Mater Interfaces. 2024 Mar 13;16(10):12310-12320. doi: 10.1021/acsami.3c19205. Epub 2024 Feb 27.
2
A Tumor-Targeting Near-Infrared Heptamethine Cyanine Photosensitizer with Twisted Molecular Structure for Enhanced Imaging-Guided Cancer Phototherapy.一种具有扭曲分子结构的肿瘤靶向近红外七甲川花菁光敏剂,用于增强成像引导的癌症光动力疗法。
J Am Chem Soc. 2021 Dec 15;143(49):20828-20836. doi: 10.1021/jacs.1c09155. Epub 2021 Dec 3.
3
Molecular Engineering of Plasma Membrane and Mitochondria Dual-Targeted NIR-II AIE Photosensitizer Evoking Synergetic Pyroptosis and Apoptosis.基于细胞膜和线粒体双重靶向的近红外二区 AIE 光敏剂的分子工程化诱导线粒体依赖性协同细胞 pyroptosis 和 apoptosis
Adv Mater. 2024 Feb;36(5):e2309488. doi: 10.1002/adma.202309488. Epub 2023 Dec 5.
4
Tumor-Targeting Near-Infrared Dimeric Heptamethine Cyanine Photosensitizers with an Aromatic Diphenol Linker for Imaging-Guided Cancer Phototherapy.具有芳香二酚连接体的肿瘤靶向近红外二聚型七甲川花菁光动力治疗剂用于成像引导的癌症光疗。
Adv Healthc Mater. 2023 Jun;12(15):e2203080. doi: 10.1002/adhm.202203080. Epub 2023 Feb 27.
5
Rationally Designed Heptamethine Cyanine Photosensitizers that Amplify Tumor-Specific Endoplasmic Reticulum Stress and Boost Antitumor Immunity.理性设计的七甲川花菁类光敏剂可放大肿瘤特异性内质网应激并增强抗肿瘤免疫。
Small. 2022 Aug;18(34):e2202728. doi: 10.1002/smll.202202728. Epub 2022 Jul 7.
6
A Mitochondria-Targeted Photosensitizer for Combined Pyroptosis and Apoptosis with NIR-II Imaging/Photoacoustic Imaging-Guided Phototherapy.一种用于联合细胞焦亡和细胞凋亡的线粒体靶向光动力剂,具有近红外二区成像/光声成像引导的光疗作用。
Angew Chem Int Ed Engl. 2024 Sep 23;63(39):e202408874. doi: 10.1002/anie.202408874. Epub 2024 Aug 21.
7
A mitochondria-targeted molecular phototheranostic platform for NIR-II imaging-guided synergistic photothermal/photodynamic/immune therapy.一种靶向线粒体的分子光热诊疗平台,用于近红外二区成像引导的协同光热/光动力/免疫治疗。
J Nanobiotechnology. 2022 Nov 11;20(1):475. doi: 10.1186/s12951-022-01679-0.
8
Anionic Cyanine J-Type Aggregate Nanoparticles with Enhanced Photosensitization for Mitochondria-Targeting Tumor Phototherapy.用于线粒体靶向肿瘤光疗的具有增强光敏性的阴离子菁J型聚集纳米颗粒。
Angew Chem Int Ed Engl. 2022 Jun 13;61(24):e202203093. doi: 10.1002/anie.202203093. Epub 2022 Apr 19.
9
Design and construction of IR780- and EGCG-based and mitochondrial targeting nanoparticles and their application in tumor chemo-phototherapy.基于 IR780 和 EGCG 的线粒体靶向纳米粒子的设计与构建及其在肿瘤化学-光疗中的应用。
J Mater Chem B. 2021 Dec 15;9(48):9932-9945. doi: 10.1039/d1tb01899j.
10
Tailoring Multifunctional Small Molecular Photosensitizers to In Vivo Self-Assemble with Albumin to Boost Tumor-Preferential Accumulation, NIR Imaging, and Photodynamic/Photothermal/Immunotherapy.定制多功能小分子光增敏剂与白蛋白在体内自组装以增强肿瘤优先积累、近红外成像以及光动力/光热/免疫治疗。
Small. 2022 Jul;18(27):e2201298. doi: 10.1002/smll.202201298. Epub 2022 Jun 2.

引用本文的文献

1
A Strategy to Design Non-Symmetric Compound by Modifying the End-Group Functional Atoms for Photothermal and Photodynamic Therapy of Tumor.通过修饰端基官能原子设计非对称化合物用于肿瘤光热和光动力治疗的策略
Int J Nanomedicine. 2025 Mar 30;20:3877-3890. doi: 10.2147/IJN.S509789. eCollection 2025.